3,4-dihydro-2(1h)-quinolinone and Degenerative Diseases, Central Nervous System

3,4-dihydro-2(1h)-quinolinone has been researched along with Degenerative Diseases, Central Nervous System in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Cheng, M; Fang, Y; Guo, J; Jin, Y; Liu, J; Wan, Y; Wang, R; Xie, SS; Xu, A	1

Other Studies

1 other study(ies) available for 3,4-dihydro-2(1h)-quinolinone and Degenerative Diseases, Central Nervous System

Article	Year
Design, Synthesis and Biological Evaluation of New 3,4-Dihydro-2(1 Drug design, development and therapy, 2022, Volume: 16 Topics: Acetylcholinesterase; Alzheimer Disease; Amyloid beta-Peptides; Animals; Cholinesterase Inhibitors; Drug Design; Humans; Hydroquinones; Kinetics; Mice; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Neurodegenerative Diseases; Quinolones; Rats; Structure-Activity Relationship	2022

Article

Year

Design, Synthesis and Biological Evaluation of New 3,4-Dihydro-2(1

Drug design, development and therapy, 2022, Volume: 16

Topics: Acetylcholinesterase; Alzheimer Disease; Amyloid beta-Peptides; Animals; Cholinesterase Inhibitors; Drug Design; Humans; Hydroquinones; Kinetics; Mice; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Neurodegenerative Diseases; Quinolones; Rats; Structure-Activity Relationship

2022